Nasus Pharma Ltd. (NSRX) Stock price, Description, News & Info

#Thinksabio latest news

Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2 Clinical Study of NS002 Intranasal Epinephrine PowderPositive Regulatory Response Marks Important Milestone for NS002 Development Program